PolyPid Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

PolyPid Stock Summary

PolyPid competes with Annovis Bio, Reviva Pharmaceuticals, Bioatla, Evaxion Biotech, and Celularity. PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform to address unmet medical needs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel. Polypid operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 75 people.

PolyPid Key Financial Ratios

PolyPid Key Balance Sheet Accounts

PolyPid Key Income Statement Accounts

PolyPid Key Cash Accounts

PolyPid Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining PolyPid's current stock value. Our valuation model uses many indicators to compare PolyPid value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PolyPid competition to find correlations between indicators driving PolyPid's intrinsic value. More Info.PolyPid is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, PolyPid's Return On Equity is projected to drop based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value PolyPid by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

PolyPid Systematic Risk

Today, most investors in PolyPid Stock are looking for potential investment opportunities by analyzing not only static indicators but also various PolyPid's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of PolyPid growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of PolyPid help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PolyPid. We use our internally-developed statistical techniques to arrive at the intrinsic value of PolyPid based on widely used predictive technical indicators. In general, we focus on analyzing PolyPid Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PolyPid's daily price indicators and compare them against related drivers.

When running PolyPid's price analysis, check to measure PolyPid's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PolyPid is operating at the current time. Most of PolyPid's value examination focuses on studying past and present price action to predict the probability of PolyPid's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PolyPid's price. Additionally, you may evaluate how the addition of PolyPid to your portfolios can decrease your overall portfolio volatility.